Morepen Laboratories Ltd: Stock Analysis & Fundamentals

Updated this week

Morepen Laboratories Ltd (Pharma - API & CRAMS) — fundamental analysis, earnings data, and key metrics. PE: 26.0. ROE: 11.8%. This stock is not currently in the Nifty 500 momentum outperformers list.

What's Happening

📊Debt increased 50% YoY — leverage rising

Key Numbers

Current Price

₹36

Dividend Yield

0.55%

Market Cap

2.0K Cr

Valuation

N/A

Other Top Pharma - API & CRAMS Stocks Beating Nifty 500

Gland Pharma Ltd

Average

+15.9%

Acutaas Chemicals Ltd

SMS Pharmaceuticals Ltd

Average • 12w streak

+37.7%

← Back to Pharma - API & CRAMS Dashboard

Frequently Asked Questions: Morepen Laboratories Ltd

Based on publicly available financial data. This is educational research, not investment advice.

What were Morepen Laboratories Ltd's latest quarterly results?

Morepen Laboratories Ltd's latest quarterly results (Dec 2025) show

PAT Growth YoY: +3.7%
Revenue Growth YoY: +6.8%
Operating Margin: 10.0%

What is Morepen Laboratories Ltd's current PE ratio?

Morepen Laboratories Ltd's current PE ratio is 26.0x.

Current PE: 26.0x
Market Cap: 2.0K Cr
Dividend Yield: 0.55%

What is Morepen Laboratories Ltd's price-to-book ratio?

Morepen Laboratories Ltd's price-to-book ratio is 1.7x.

Price-to-Book (P/B): 1.7x
Book Value per Share: ₹22
Current Price: ₹36

Is Morepen Laboratories Ltd a fundamentally strong company?

Morepen Laboratories Ltd's fundamental strength based on key financial ratios

Return on Capital (ROCE): 15.0%

Is Morepen Laboratories Ltd debt free?

Morepen Laboratories Ltd has a debt-to-equity ratio of N/A.

Total Debt: ₹105 Cr

What is Morepen Laboratories Ltd's return on equity (ROE) and ROCE?

Morepen Laboratories Ltd's return ratios over recent years

FY2023: ROCE 8.0%
FY2024: ROCE 17.0%
FY2025: ROCE 15.0%

Is Morepen Laboratories Ltd's cash flow positive?

Morepen Laboratories Ltd's operating cash flow is positive (FY2025).

Cash from Operations (CFO): ₹32 Cr
Free Cash Flow (FCF): ₹-290 Cr
CFO/PAT Ratio: 27% (weak cash conversion)

What is Morepen Laboratories Ltd's dividend yield?

Morepen Laboratories Ltd's current dividend yield is 0.55%.

Dividend Yield: 0.55%
Current Price: ₹36

Who holds Morepen Laboratories Ltd shares — promoters, FII, DII?

Morepen Laboratories Ltd's shareholding pattern (Dec 2025)

Promoters: 35.7%
FII (Foreign): 1.6%
DII (Domestic): 1.3%
Public: 61.5%

Is promoter holding increasing or decreasing in Morepen Laboratories Ltd?

Morepen Laboratories Ltd's promoter holding has remained stable recently.

Current Promoter Holding: 35.7% (Dec 2025)
Previous Quarter: 35.7% (Sep 2025)
Change: 0.00% (stable)

Is Morepen Laboratories Ltd a new momentum entry or an established outperformer?

Morepen Laboratories Ltd is an established outperformer with 1 weeks of consecutive Nifty 500 outperformance.

Is Morepen Laboratories Ltd worth studying for long term investment?

Based on quantitative research signals, here is why Morepen Laboratories Ltd may be worth studying

Cash flow is positive — CFO ₹32 Cr

What is the investment thesis for Morepen Laboratories Ltd?

Morepen Laboratories Ltd investment thesis summary:

What is the future outlook for Morepen Laboratories Ltd?

Morepen Laboratories Ltd's forward outlook based on current data signals

Insufficient data for a forward assessment — monitoring for more signals

The above FAQs are generated from publicly available earnings data and conference call transcripts. This is educational research only. Sector Alpha is not SEBI registered and does not provide investment advice.